Francesco Loconsole

Bari, 70121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Therapeutic outcomes of CAL/BDP PAD-based cream in patients with mild-to-moderate psoriasis: insights from four case reports.

Therapeutic outcomes of CAL/BDP PAD-based cream in patients with mild-to-moderate psoriasis: insights from four case reports.

Journal: Drugs in context

Published: May 11, 2026

Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Journal: Journal of clinical medicine

Published: April 17, 2026

Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.

Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.

Journal: Dermatology and therapy

Published: April 10, 2026

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).

Journal: Dermatology and therapy

Published: March 17, 2026

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Journal: Dermatology and therapy

Published: March 04, 2026

Toward the definition of moderate psoriasis: an expert opinion.

Toward the definition of moderate psoriasis: an expert opinion.

Journal: The Journal of dermatological treatment

Published: February 23, 2026

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.

Journal: The Journal of dermatological treatment

Published: February 06, 2026

Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).

Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).

Journal: Dermatology and therapy

Published: December 01, 2025

Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian Study.

Long-Term Effectiveness of Bimekizumab in Plaque Psoriasis: Two-Year Drug Survival from a Real-Life Multicenter Italian Study.

Journal: Clinical and experimental dermatology

Published: October 23, 2025

Long-term effectiveness of bimekizumab in plaque psoriasis: 2-year drug survival from a real-life multicentre Italian study.

Long-term effectiveness of bimekizumab in plaque psoriasis: 2-year drug survival from a real-life multicentre Italian study.

Journal: Clinical and experimental dermatology

Published: October 23, 2025

Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis).

Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis).

Journal: Clinical and experimental dermatology

Published: June 24, 2025

GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs.

GRINCH Index: Measuring Patient Satisfaction During Christmas Holiday Gift Programs.

Journal: Dermatology practical & conceptual

Published: June 11, 2025

Showing 1-12 of 88

Last Updated: 09/26/2026